Adjunctive fluoxetine improves global function in chronic schizophrenia

M. B. Goldman, H. M. Janecek

Research output: Contribution to journalArticlepeer-review

35 Scopus citations


Eight chronic schizophrenic inpatients received adjunctive fluoxetine (20 mg/day) for a mean of 10.6 weeks in an open clinical trial. Clinical state improved in all patients. Violent incidents decreased, while participation in programs and socialization increased.

Original languageEnglish (US)
Pages (from-to)429-431
Number of pages3
JournalJournal of Neuropsychiatry and Clinical Neurosciences
Issue number4
StatePublished - Jan 1 1990

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health


Dive into the research topics of 'Adjunctive fluoxetine improves global function in chronic schizophrenia'. Together they form a unique fingerprint.

Cite this